Medical device makers including Abbott, Johnson & Johnson and Medtronic want an exemption from Trump tariffs that could hit ...

India's top Army hospital has successfully performed the country's first government-based LVAD implantation, akin to a 'mechanical heart', offering new hope to patients with end-stage heart failure.

Patients with preexisting indications for aspirin therapy—including those with a history of revascularization, stroke, or peripheral vascular disease—may not need the drug after receiving the ...

Doctors wanted to implant a left ventricular assist device (LVAD) called the Abbott HeartMate 3 LVAD to allow her heart to rest and recover. A LVAD assists the heart by pumping blood from the left ...

The left ventricular assist device market segment will reach $2.24bn by 2033. Abbott’s HeartMate 3 is the current market leader in the field and was approved by the FDA for less invasive ...

has performed "India's first-ever Left Ventricular Assist Device (LVAD) implantation using the HeartMate 3 device in a government institution. This marks a historic first for the Armed Forces ...

has performed India's first-ever Left Ventricular Assist Device (LVAD) implantation using the HeartMate 3 device in a government institution. This marks a historic first for the Armed Forces ...

Abbott's HEARTMATE II LVAD has been used in more than 26,600 patients worldwide. As stated by the American College of Cardiology, hospital readmissions related to LVAD are frequently expensive and ...

The HeartMate VE Left Ventricular Assist Device (vented electric abdominally positioned pulsatile blood pump; Thoratec Corp., Pleasanton, CA), approved as a permanent support, or destination ...

In a groundbreaking achievement, Army Hospital (Research & Referral), Delhi Cantt, has successfully performed India’s first-ever Left Ventricular Assist Device (LVAD) implantation using the HeartMate ...